JPRN-UMIN000018618已完成未知
Assessment of Safety and Efficacy of Rapid Exchange Fractional Flow Reserve Microcatheter in Patients with Intermediate Coronary Stenosis - FFR by Rapid Exchange Microcatheter
Wakayama Medical University Department of Cardiovascular Medicine0 个研究点目标入组 36 人开始时间: 2015年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Chronic total occlusion 2)Acute myocardial infarction 3)Contraindication for adenosine triphosphate 4)Patients with severe reduced ejection fraction or severe valvular disease 5)Patients who can not provide written informed consents 6)Patients who were not suitable for enrollment
研究者
相似试验
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of Extraneal Physiological pH Compared with Current Extraneal in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD).End Stage Renal Disease patients receiving continuous ambulatiry peritoneal dialysis (CAPD)MedDRA version: 6.1 Level: LLT Classification code 10014646EUCTR2004-001388-23-DEBaxter R&D Europe SCR120
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of Extraneal Physiological pH Compared with Current Extraneal in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD).End Stage Renal Disease patients receiving continuous ambulatiry peritoneal dialysis (CAPD)MedDRA version: 6.1 Level: LLT Classification code 10014646EUCTR2004-001388-23-DKBaxter R&D Europe SCR120
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of Extraneal Physiological pH Compared with Current Extraneal in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD).End Stage Renal Disease patients receiving continuous ambulatiry peritoneal dialysis (CAPD)MedDRA version: 6.1 Level: LLT Classification code 10014646EUCTR2004-001388-23-GBBaxter R&D Europe SCR120
进行中（未招募）
不适用
A Study to Evaluate the Efficacy and Safety of Extraneal Physiological pH Compared with Current Extraneal in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD).End Stage Renal Disease patients receiving continuous ambulatiry peritoneal dialysis (CAPD)MedDRA version: 6.1Level: LLTClassification code 10014646EUCTR2004-001388-23-SEBaxter R&D Europe SCR120
已完成
不适用
Evaluation of the efficacy and safety for switching from premixed insulin to ultra-long acting insulin plus ultra-rapid insulitype 2 diabetesJPRN-UMIN000009562Department of Endocrinology and Metabolism, Nagoya City West Medical Center40